Sino Biopharmaceutical Ltd (SBHMY)
7.20
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Sino Biopharmaceutical Market Cap: 6.765B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 6.765B |
| May 02, 2024 | 6.765B |
| May 01, 2024 | 6.765B |
| April 30, 2024 | 6.765B |
| April 29, 2024 | 6.765B |
| April 26, 2024 | 6.765B |
| April 25, 2024 | 6.765B |
| April 24, 2024 | 6.765B |
| April 23, 2024 | 6.768B |
| April 22, 2024 | 6.768B |
| April 19, 2024 | 6.768B |
| April 18, 2024 | 6.768B |
| April 17, 2024 | 6.768B |
| April 16, 2024 | 6.768B |
| April 15, 2024 | 6.768B |
| April 12, 2024 | 6.768B |
| April 11, 2024 | 6.768B |
| April 10, 2024 | 6.768B |
| April 09, 2024 | 6.768B |
| April 08, 2024 | 6.768B |
| April 05, 2024 | 6.966B |
| April 04, 2024 | 6.966B |
| April 03, 2024 | 6.947B |
| April 02, 2024 | 7.708B |
| April 01, 2024 | 7.708B |
| Date | Value |
|---|---|
| March 28, 2024 | 7.708B |
| March 27, 2024 | 7.708B |
| March 26, 2024 | 7.708B |
| March 25, 2024 | 7.708B |
| March 22, 2024 | 7.708B |
| March 21, 2024 | 7.708B |
| March 20, 2024 | 7.708B |
| March 19, 2024 | 7.708B |
| March 18, 2024 | 7.708B |
| March 15, 2024 | 6.994B |
| March 14, 2024 | 6.994B |
| March 13, 2024 | 6.994B |
| March 12, 2024 | 6.994B |
| March 11, 2024 | 6.994B |
| March 08, 2024 | 6.994B |
| March 07, 2024 | 6.994B |
| March 06, 2024 | 6.994B |
| March 05, 2024 | 6.994B |
| March 04, 2024 | 7.483B |
| March 01, 2024 | 7.483B |
| February 29, 2024 | 7.483B |
| February 28, 2024 | 7.483B |
| February 27, 2024 | 7.483B |
| February 26, 2024 | 7.112B |
| February 23, 2024 | 7.112B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
6.298B
Minimum
Oct 20 2023
24.94B
Maximum
Jul 17 2020
13.63B
Average
12.95B
Median
Feb 22 2022
Market Cap Benchmarks
| HUTCHMED (China) Ltd | 3.269B |
| Pharmaron Beijing Co Ltd | 2.906B |
| Regencell Bioscience Holdings Ltd | 69.36M |
| Prenetics Global Ltd | 63.83M |
Market Cap Related Metrics
| PE Ratio | 20.29 |
| PS Ratio | 1.809 |
| Price to Book Value | 1.574 |
| Price to Free Cash Flow | 10.90 |
| Price | 7.20 |
| Earnings Yield | 4.93% |
| Operating PE Ratio | 8.190 |
| Normalized PE Ratio | 24.39 |